Mar 07, 2023

If You Have a Horse, You Have an Athlete: Tips for Managing Degenerative Joint Disease in Your Equine Athlete

By Adequan - Sponsor
Image courtesy of American Regent, Inc.

Estimates indicate up to 60 percent of lameness in the horse is related to end-stage degenerative joint disease (DJD), also known as osteoarthritis (OA). DJD can influence performance and significantly impact any horse—from top competitors and weekend warriors to aging seniors.

Daily training, competition, and riding, not to mention age-related degenerative processes, can all lead to a disruption in a healthy joint’s natural wear and repair cycle. Your veterinarian can help by observing the signs of DJD in your horse, diagnosing the disease early and starting treatment with a product that treats the disease, not just the clinical signs.

For over 30 years, Adequan® i.m. (polysulfated glycosaminoglycan) has been used millions of times by leading veterinarians2 because it is proven to help: reduce inflammation, restore synovial joint lubrication, repair joint cartilage and reverse the disease process.3,4 It’s a powerful tool in the fight against equine DJD.

Six tips for managing OA in your horse:

  • Maintain your horse’s healthy weight—excess weight can put considerable stress on joints
  • Encourage regular exercise—activity is essential for a horse’s healthy joints
  • Allow appropriate cooling out after vigorous exercise
  • Provide balanced nutrition, especially during the growth phase
  • Schedule regular veterinary well-checks—monitoring for signs of osteoarthritis allows your veterinarian to make an early diagnosis and start treatment before the disease worsens or becomes irreversible
  • Ask your veterinarian about Adequan i.m.—the only FDA-approved polysulfated glycosaminoglycan (PSGAG) and an important first-line treatment for DJD because of its ability to produce disease-modifying effects5

Discover if Adequan® i.m. is the right choice for your horse. Visit adequan.com for more information.

INDICATIONS

Adequan® i.m. (polysulfated glycosaminoglycan) is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

IMPORTANT SAFETY INFORMATION There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For full prescribing information, visit adequan.com.

1 McIlwraith CW, Frisbie DD, Kawcak CE, van Weeren PR. Joint Disease in the Horse. St. Louis, MO: Elsevier, 2016; 33-48.
2 Data on File, American Regent Animal Health, Inc.
3 Burba DJ, Collier MA, DeBault LE, Hanson-Painton O, Thompson HC, Holder CL: In vivo kinetic study on uptake and distribution of intramuscular tritium-labeled polysulfated glycosaminoglycan in equine body fluid compartments and articular cartilage in an osteochondraldefect model. J Equine Vet Sci 1993; 13: 696-703.
4 Adequan® i.m. Package Insert, REV 1/19.
5 McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis. Bone Joint Res 2012; 1: 297-309.
All trademarks are the property of American Regent, Inc.
© 2022, American Regent, Inc. PP-AI-US-0772 5/2022
Sep 29, 2023 Education

The Eventing Coaches Program Focuses on Area and Regional Needs

The USEA Eventing Coaches Program (ECP) has initiated a renewed focus on the diverse challenges coaches in various regions of the country may be facing. To this end, the program is in the process of enlisting representatives in each of the 10 USEA areas to help guide the program as warranted for the unique needs of each specific area.

Sep 28, 2023 Awards

Nominations for 2023 USEA Appreciation Awards Now Open through October 29

The United States Eventing Association (USEA) has opened nominations for the annual appreciation awards through Oct. 29. This is an opportunity for the sport to recognize those horses and riders who excelled in eventing throughout the year. It is also an opportunity to recognize and honor the very important people who have served the sport tirelessly both in a non-riding capacity and riding capacity during their golden years.

Sep 28, 2023 Interscholastic

Stable View is Ramping Up for the 2024 Intercollegiate & IEL Championships

Anticipation for the 2024 USEA Intercollegiate Eventing Championship and inaugural USEA Interscholastic Eventing League (IEL) Championship is growing, and the host venue, Stable View, is up for the task of making both events an unforgettable experience for all involved. For the first time, the Intercollegiate and IEL program championships will be hosted on the same weekend at the Stable View H.T. in Aiken, South Carolina, on May 4-5, 2024, creating greater unity between the programs and demonstrating a clear pipeline of participation in the sport from grade school through college and beyond.

Sep 27, 2023 Rules

New Eventing Rule Changes Going into Effect October 1, 2023

The United States Equestrian Federation (USEF) has made five rule changes which will go into effect October 1, 2023. Familiarize yourself with these rule changes below to make sure you are in compliance before heading out for your next event.

Official Corporate Sponsors of the USEA

Official Joint Therapy Treatment of the USEA

Official Feed of the USEA

Official Saddle of the USEA

Official Real Estate Partner of the USEA

Official Equine Insurance of the USEA

Official Forage of the USEA

Official Supplement Feeding System of the USEA

Official Competition & Training Apparel of the USEA